Literature DB >> 6441218

CO2 elimination and airway opening pressure during high frequency oscillation in dogs.

J W Watson, A C Jackson, J R Gillespie.   

Abstract

CO2 elimination (VCO2) and pressure at the airway opening (Pao) were measured over a wide range of frequencies (f) (5-40 Hz) and tidal volumes (VT) (1-45 ml) during high frequency oscillatory ventilation (HFO) in 11 anesthetized, paralyzed dogs. CO2 elimination was found to depend primarily on the product off and VT which is consistent with theoretical predictions of gas exchange by augmented dispersion. Airway opening pressures during HFO were frequency dependent. At frequencies near 5 Hz Pao was lower, while at frequencies above 5 Hz Pao was higher than Pao during conventional mechanical ventilation (12 cm H2O). The minimum Pao (5 cm H2O) achieved while maintaining VCO2 equivalent to normal metabolic CO2 production occurred when VT was near that of the dead space volume and frequency was near 5 Hz. At lower VT, higher frequencies were required to maintain VCO2 and this increased frequency resulted in an increase in Pao amplitude (10-15 cm H2O).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6441218     DOI: 10.1016/0034-5687(84)90151-8

Source DB:  PubMed          Journal:  Respir Physiol        ISSN: 0034-5687


  3 in total

1.  Bringing back the old: time to reevaluate the high-frequency ventilation strategy.

Authors:  A Mukerji; J Belik; M Sanchez-Luna
Journal:  J Perinatol       Date:  2014-03-13       Impact factor: 2.521

2.  Using very high frequencies with very low lung volumes during high-frequency oscillatory ventilation to protect the immature lung. A pilot study.

Authors:  N González-Pacheco; M Sánchez-Luna; C Ramos-Navarro; N Navarro-Patiño; A R-S de la Blanca
Journal:  J Perinatol       Date:  2016-01-07       Impact factor: 2.521

3.  Effect of a new respiratory care bundle on bronchopulmonary dysplasia in preterm neonates.

Authors:  Cristina Ramos-Navarro; Noelia González-Pacheco; Ana Rodríguez-Sánchez de la Blanca; Manuel Sánchez-Luna
Journal:  Eur J Pediatr       Date:  2020-06-02       Impact factor: 3.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.